Isosorbide Mononitrate: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Isosorbide Mononitrate. Educational only — not medical advice.

Labeled uses

Isosorbide mononitrate extended-release tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Source: FDA labeling via NIH DailyMed (set d01d4f0f…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.